Liu Xishi, Yuan Lei, Shen Fanghua, Zhu Zhilin, Jiang Hongyuan, Guo Sun-Wei
Department of Gynecology, Shanghai OB/GYN Hospital, Shanghai, China.
Obstet Gynecol. 2007 Jun;109(6):1411-20. doi: 10.1097/01.AOG.0000265215.87717.8b.
To identify risk factors for and the patterns of recurrence of endometrioma and of dysmenorrhea in women with ovarian endometrioma.
We evaluated 710 consecutive patients operated on for ovarian endometriomas who were followed up for an average of 22.4 months. Twenty factors were examined to assess their effect on risk of recurrence of endometrioma and of dysmenorrhea using survival analysis. Hazard rate also was estimated to examine recurrence patterns.
For recurrence of endometrioma, the revised American Fertility Society (rAFS) score, younger age at surgery, and previous medical treatment of endometriosis were identified to be risk factors. For recurrence of dysmenorrhea, rAFS score was the only risk factor. For both recurrences, there was a constant hazard rate in the first 28-30 months after surgery, indicating that the recurrence in that period is completely random. After that period, the hazard rate increased dramatically.
The total rAFS score, but not rAFS stage, is a risk factor for recurrence of both endometrioma and dysmenorrhea, indicating that the rAFS stage has little prognostic value. The existence of a completely random recurrence period may be a universal phenomenon, with its duration and the magnitude of recurrence risk determined by patient characteristics and quality of care. The second phase of much higher recurrence risk may reflect successful reseeding, reimplantation, and regrowth of ectopic endometrium. Therefore, the identification of risk factors as well as patterns of recurrence should shed better light on possible causes for recurrence, which is now poorly understood.
确定卵巢子宫内膜异位囊肿患者子宫内膜异位囊肿和痛经复发的危险因素及复发模式。
我们评估了710例连续接受卵巢子宫内膜异位囊肿手术的患者,平均随访22.4个月。通过生存分析检查20个因素,以评估它们对子宫内膜异位囊肿和痛经复发风险的影响。还估计了风险率以检查复发模式。
对于子宫内膜异位囊肿复发,美国生殖医学协会(rAFS)修订评分、手术时年龄较小以及既往子宫内膜异位症治疗情况被确定为危险因素。对于痛经复发,rAFS评分是唯一的危险因素。对于两种复发情况,术后前28 - 30个月风险率恒定,表明该时期的复发完全是随机的。在此之后,风险率急剧上升。
rAFS总分而非rAFS分期是子宫内膜异位囊肿和痛经复发的危险因素,表明rAFS分期预后价值不大。完全随机的复发期的存在可能是一种普遍现象,其持续时间和复发风险大小由患者特征和护理质量决定。复发风险高得多的第二阶段可能反映了异位子宫内膜成功种植、重新植入和再生长。因此,确定危险因素以及复发模式应能更好地揭示复发的可能原因,目前对复发原因了解甚少。